Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 7279818, 8 pages
https://doi.org/10.1155/2017/7279818
Review Article

Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?

1Clinic of Dermatology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
2Clinic of Dermatology, Tartu University Hospital, 31 Raja St., 50417 Tartu, Estonia
3Institute of Biomedicine and Translational Medicine, Department of Biochemistry, The Centre of Excellence for Genomics and Translational Medicine, University of Tartu, 19 Ravila St., 50411 Tartu, Estonia

Correspondence should be addressed to Sirje Kaur; ee.mukiniilk@ruak.ejris

Received 18 May 2017; Revised 1 August 2017; Accepted 7 August 2017; Published 29 August 2017

Academic Editor: Anna Balato

Copyright © 2017 Sirje Kaur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Sirje Kaur, Külli Kingo, and Mihkel Zilmer, “Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?,” Mediators of Inflammation, vol. 2017, Article ID 7279818, 8 pages, 2017. https://doi.org/10.1155/2017/7279818.